Prospective trial comparing the use of sulphasalazine and auranofin as second line drugs in patients with rheumatoid arthritis.

Two hundred patients with rheumatoid arthritis were studied in a prospective open trial comparing treatment with sulphasalazine and auranofin in patients with active disease over 12 months. The two drugs improved many parameters of disease activity at 12, 24, and 48 weeks. At 12 weeks, the group tre...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Ann Rheum Dis
Autori principali:	Porter, D, Madhok, R, Hunter, J A, Capell, H A
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMJ Publishing Group 1992
Soggetti:	Research Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1004691/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1350192/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.51.4.461
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!